13:06 IST
BSE
Annual General Meeting
Skybiotech Healthcare Annual General Meeting
Skybiotech Healthcare Ltd has issued the notice for its 43rd Annual General Meeting. The meeting is scheduled to be held on September 30, 2026.
Skybiotech Healthcare Ltd
- Share price
- ₹116.20
- Market cap
- ₹22.25 Cr
- Revenue (annual)
- ₹7.10 Cr
- Net profit (annual)
- ₹-1.12 Cr
- P/E (TTM)
- -13.3×Sector 50.4×
- Promoter holding
- 63.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 2Financial Results 1Board Meeting Date 1Annual Report 1Annual General Meeting 1
Time
6 announcements with these filters
12:37 IST
BSE
Annual Report
Skybiotech Healthcare Annual Report
Skybiotech Healthcare Ltd has filed its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.
20:59 IST
BSE
Financial Results
Skybiotech Healthcare Q1 FY27 Results: Net Loss of ₹0.6 Cr
Skybiotech Healthcare Ltd reported revenue from operations of ₹0.5 Cr (-79.2% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.6 Cr
14:36 IST
BSE
Board Meeting Date
Skybiotech Healthcare Board Meeting Date
Skybiotech Healthcare Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve un-audited financial results for the quarter ended June 30, 2026.
18:57 IST
BSE
Other Announcement
Skybiotech Healthcare Other Announcement
Skybiotech Healthcare Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, as required by SEBI regulations.
11:58 IST
BSE
Other Announcement
Skybiotech Healthcare Other Announcement
Skybiotech Healthcare Ltd has filed its quarterly shareholding pattern statement as per regulatory requirements. This document details the company's equity distribution across various shareholder categories.